Zimmer Biomet Holdings, Inc. to Issue Quarterly Dividend of $0.24 (NYSE:ZBH)

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced a quarterly dividend on Friday, May 22nd. Investors of record on Thursday, June 25th will be given a dividend of 0.24 per share by the medical equipment provider on Friday, July 31st. This represents a c) annualized dividend and a yield of 1.1%. The ex-dividend date is Thursday, June 25th.

Zimmer Biomet has a dividend payout ratio of 11.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Zimmer Biomet to earn $8.91 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.8%.

Zimmer Biomet Stock Down 0.8%

Shares of Zimmer Biomet stock opened at $87.29 on Tuesday. Zimmer Biomet has a 12-month low of $79.12 and a 12-month high of $108.29. The company has a quick ratio of 0.95, a current ratio of 1.73 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $87.13 and a two-hundred day moving average price of $90.05. The stock has a market capitalization of $16.89 billion, a P/E ratio of 22.67, a PEG ratio of 2.59 and a beta of 0.47.

Zimmer Biomet (NYSE:ZBH) last released its quarterly earnings results on Tuesday, April 28th. The medical equipment provider reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.23. The company had revenue of $2.09 billion for the quarter, compared to analyst estimates of $2.07 billion. Zimmer Biomet had a net margin of 9.05% and a return on equity of 13.24%. The company’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 earnings per share. Zimmer Biomet has set its FY 2026 guidance at 8.400-8.550 EPS. Equities analysts expect that Zimmer Biomet will post 8.49 earnings per share for the current year.

Zimmer Biomet Company Profile

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.